DISEASE INDICATIONS: Psoriasis

MANUFACTURER: Janssen Biotech

USAGE: Subcutaneous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Pharmaceuticals and Medical Devices Agency (PMDA)

Therapeutic Goods Administration (TGA)

Tremfya is an injectable medication used to treat moderate to severe plaque psoriasis. It targets the protein interleukin-23 (IL-23), which plays a key role in psoriasis development.